Edge Capital Group, LLC Eli Lilly & CO Transaction History

Edge Capital Group, LLC

$2.21 Billion
Q3 2024

A detailed history of Edge Capital Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Edge Capital Group, LLC holds 11,944 shares of LLY stock, worth $9.5 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

11,944

Previous 13,513 11.61%

Holding current value

$9.5 Million

Previous $12.2 Million 13.51%

% of portfolio

0.48%

Previous 0.6%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $1.21 Million - $1.51 Million	-1,569 Reduced 11.61%	11,944 $10.6 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $39,142 - $49,088	-54 Reduced 0.4%	13,513 $12.2 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $245,763 - $328,796	-415 Reduced 2.97%	13,567 $10.6 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $278,350 - $328,138	530 Added 3.94%	13,982 $8.15 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1.94 Million - $2.68 Million	-4,467 Reduced 24.93%	13,452 $7.23 Million
Q2 2023 Aug 08, 2023	BUY	$350.74 - $468.98 $312,509 - $417,861	891 Added 5.23%	17,919 $8.4 Million
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $1.05 Million - $1.24 Million	3,390 Added 24.86%	17,028 $5.85 Million
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $209,650 - $244,284	652 Added 5.02%	13,638 $4.99 Million
Q3 2022 Nov 09, 2022	BUY	$296.48 - $337.87 $77,381 - $88,184	261 Added 2.05%	12,986 $4.2 Million
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $175,042 - $205,525	628 Added 5.19%	12,725 $4.13 Million
Q1 2022 May 03, 2022	BUY	$234.69 - $291.66 $351,565 - $436,906	1,498 Added 14.13%	12,097 $3.46 Million
Q4 2021 Jan 19, 2022	BUY	$224.85 - $279.04 $5,846 - $7,255	26 Added 0.25%	10,599 $2.93 Million
Q3 2021 Oct 26, 2021	SELL	$221.6 - $272.71 $1.61 Million - $1.98 Million	-7,245 Reduced 40.66%	10,573 $2.44 Million
Q2 2021 Aug 09, 2021	BUY	$180.55 - $233.54 $94,427 - $122,141	523 Added 3.02%	17,818 $4.09 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $108,122 - $139,969	658 Added 3.96%	17,295 $3.23 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $541,930 - $717,105	4,154 Added 33.28%	16,637 $2.81 Million
Q3 2020 Nov 09, 2020	BUY	$146.22 - $169.13 $1.83 Million - $2.11 Million	12,483 New	12,483 $1.85 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edge Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edge Capital Group, LLC with notifications on news.

Account

Edge Capital Group, LLC Eli Lilly & CO Transaction History